Can a probiotic stop bacterial vaginosis recurrence?

NCT ID NCT07527572

Not yet recruiting Disease control Sponsor: Kaneka Americas Holding Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a probiotic called Lactobacillus gasseri KABP®064 can prevent bacterial vaginosis (BV) from returning after standard antibiotic treatment. BV is a common vaginal infection that often comes back within a year. The trial will involve 160 women with a history of recurrent BV. Participants will take either the probiotic or a placebo daily for 15 days, then 10 days per month for six months, and researchers will track how many have a recurrence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Lactobacillus gasseri KABP®064 (a probiotic)
What this could lead to: If it works, this could offer a non-antibiotic way to reduce the high rate of bacterial vaginosis recurrence, improving vaginal health and quality of life.
What could go wrong: This is an early-phase trial (Phase 2/3) with only 160 participants. The probiotic may not prevent recurrence better than placebo, and individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTERIAL VAGINOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bacterial vaginosis Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BACTERIAL VAGINOSIS BACTERIAL VAGINOSIS (BV) VAGINOSIS, BACTERIAL

More trials for these conditions

Other studies related to the condition(s) this trial covers.